Trexquant Investment’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-121,746
| Closed | -$4.51M | – | 1556 |
|
2023
Q4 | $4.51M | Buy |
121,746
+115,022
| +1,711% | +$4.26M | 0.1% | 287 |
|
2023
Q3 | $244K | Buy |
+6,724
| New | +$244K | 0.01% | 1293 |
|
2023
Q2 | – | Sell |
-50,113
| Closed | -$1.78M | – | 1566 |
|
2023
Q1 | $1.78M | Sell |
50,113
-40,567
| -45% | -$1.44M | 0.05% | 500 |
|
2022
Q4 | $3.19M | Buy |
+90,680
| New | +$3.19M | 0.09% | 296 |
|
2022
Q3 | – | Sell |
-63,907
| Closed | -$3.48M | – | 1550 |
|
2022
Q2 | $3.48M | Buy |
63,907
+43,260
| +210% | +$2.35M | 0.16% | 150 |
|
2022
Q1 | $1.12M | Buy |
20,647
+14,729
| +249% | +$802K | 0.05% | 443 |
|
2021
Q4 | $326K | Buy |
+5,918
| New | +$326K | 0.02% | 870 |
|
2021
Q1 | – | Sell |
-24,348
| Closed | -$1.12M | – | 1248 |
|
2020
Q4 | $1.12M | Buy |
+24,348
| New | +$1.12M | 0.12% | 231 |
|
2019
Q2 | – | Sell |
-102,469
| Closed | -$5.35M | – | 930 |
|
2019
Q1 | $5.35M | Buy |
+102,469
| New | +$5.35M | 0.38% | 51 |
|
2018
Q1 | – | Sell |
-11,903
| Closed | -$528K | – | 1198 |
|
2017
Q4 | $528K | Buy |
+11,903
| New | +$528K | 0.06% | 489 |
|
2017
Q1 | – | Sell |
-4,960
| Closed | -$239K | – | 1170 |
|
2016
Q4 | $239K | Buy |
+4,960
| New | +$239K | 0.04% | 745 |
|
2016
Q1 | – | Sell |
-56,214
| Closed | -$2.84M | – | 1009 |
|
2015
Q4 | $2.84M | Buy |
+56,214
| New | +$2.84M | 0.25% | 83 |
|